Unlocking the potential of ion channel biologics

TetraGenetics’ breakthrough technology produces unprecedented levels of correctly folded and functional membrane-spanning proteins that enable the discovery of novel therapeutic antibodies.

Like Comment
Page of
Go to the profile of TetraGenetics

TetraGenetics

TetraGenetics is focused on the discovery and development of first-in-class biologic medicines for autoimmune diseases, oncology and pain. The company has the leading drug discovery platform (TetraExpress™) for identifying antibodies targeting ion channels and other transmembrane proteins. TetraGenetics is actively building a proprietary drug pipeline and working collaboratively with major biotech companies for antibody drug discovery.

No comments yet.